Nhoa SA
SWB:8XE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nhoa SA
SWB:8XE
|
FR |
|
SFD SA
F:7PQ
|
PL |
|
C
|
CSPC Pharmaceutical Group Ltd
OTC:CSPCY
|
CN |
|
R
|
Revance Therapeutics Inc
F:RTI
|
US |
|
Equitable Holdings Inc
F:AXJ
|
US |
|
A
|
Australian Vanadium Ltd
OTC:ATVVF
|
AU |
|
A
|
Arrow Electronics Inc
XMUN:ARW
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
OTC:MURGY
|
DE |
|
O
|
Outcrop Silver & Gold Corp
XMUN:MRG
|
CA |
|
G
|
Gentex Corp
XMUN:GTX
|
US |
Wall St Price Targets
8XE Price Targets Summary
Nhoa SA
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8XE's stock price target?
Not Available
8XE does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nhoa SA?
Projected CAGR
53%
Over the last 6 years, the compound annual growth rate for Revenue has been 74%. The projected CAGR for the next 3 years is 53%.